Merrimack Pharmaceuticals (NASDAQ:MACK), NPS

10-02-2014 Market News CallComments (0)

Merrimack PharmaceuticalsPharmaceutical

Merrimack Pharmaceuticals (NASDAQ:MACK)'s shares gained 4.59% and closed at $4.79. The company on Jan. 23 announced enrollment of its first patient in a Phase 1 dose-escalating clinical study of MM-398 in conjunction with cyclophosphamide for ...

Read more on Market News Call

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top